Patents Assigned to MetaMorphix International, Inc.
  • Immunological methods to modulate myostatin in vertebrate subjects
    Publication number: 20030065137
    Abstract: Immunological compositions and methods for reducing myostatin activity in vertebrate subjects are disclosed. The compositions include myostatin peptide immunogens, myostatin multimers and or myostatin immunoconjugates capable of eliciting an immune response in a vertebrate subject to which the compositions are administered. The methods are useful for the treatment of a wide variety of disorders.
    Type: Application
    Filed: February 11, 2002
    Publication date: April 3, 2003
    Applicant: MetaMorphix International, Inc.
    Inventors: Christopher A. Barker, Mohamad Morsey
  • Myostatin multimers
    Patent number: 6369201
    Abstract: Immunological compositions and methods for reducing myostatin activity in vertebrate subjects are disclosed. The compositions include myostatin peptide immunogens, myostatin multimers and or myostatin immunoconjugates capable of eliciting an immune response in a vertebrate subject to which the compositions are administered. The methods are useful for the treatment of a wide variety of disorders.
    Type: Grant
    Filed: February 18, 1999
    Date of Patent: April 9, 2002
    Assignee: MetaMorphix International, Inc.
    Inventors: Christopher A. Barker, Mohamad Morsey